Peter White

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 20:58, March 16, 2018 by Kmdenmark (talk | contribs) (typo; added name to ref)
Peter white.png

Peter D. White is a British psychiatrist. He is Professor of Psychological Medicine, honorary consultant liaison psychiatrist at St Bartholomew's hospital and co-leads the chronic fatigue syndrome (CFS) service. Prof White was the lead investigator on the PACE trial. Prof White also funded and was involved in the Cochrane review of GET.[1]

Links to Insurance Industry[edit | edit source]

Peter White has consulted for the insurance industry.[2] He did not disclose his financial conflicts of interest to the participants of the PACE Trial, of which he was the lead investigator.[1] David Tuller has written critically about the links the PACE trial investigators have to the insurance industry.[3]

Prof White resigned from clinical practice just before he was compelled by an order of the court to release the raw data from the PACE trial.[1]

Notable studies and articles related to ME/CFS[edit | edit source]

Talks & interviews[edit | edit source]

Books[edit | edit source]

Online presence/List of Publications[edit | edit source]

Directorships and Shareholdings[edit | edit source]

Peter Denton White is a director and has 2 total appointments. He is a director of OneHealth (Company number 04364122) from 2002 to 2010. The memorandum of association states that the purpose is to promote the biopsychosocial model of illness. He is also a director of Added Value Advisory Services (Company number 03764154) from 1999 to date.

None of these have been disclosed in his research work and publications.

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 Williams, Margaret (September 14, 2016), Proof Positive (revisited) (PDF)
  2. White, Peter D (2011), "Managing claims for chronic fatigue the active way", Swiss Re (insurance), archived from the original on July 25, 2013
  3. Tuller, David (November 17, 2015), "Trial By Error, Continued: PACE Team's Work for Insurance Companies Is "Not Related" to PACE. Really?", Virology Blog
  4. Collin, Simon M, Bakken, Inger J, Nazareth, Irwin, Crawley, Esther and White, Peter D, 2017, 'Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001–2013: a Clinical Practice Research Datalink study'. J R Soc Med, 110(6): 231–244. DOI: 10.1177/0141076817702530
  5. Sharpe, M; Chalder, T; Johnson, AL; Goldsmith, KA; White, PD (2017), "Response to: Do more people recover from chronic fatigue syndrome with cognitive behaviour therapy or graded exercise therapy than with other treatments?", Fatigue: Biomedicine, Health & Behavior, 5 (1), doi:10.1080/21641846.2017.1288629
  6. P. D. White, K. E. Nye, A. J. Pinching, T. M. Yap, N. Power, V. Vleck, D. J. Bentley, J. M. Thomas, M. Buckland & J. M. Parkin. (2004). Immunological Changes After Both Exercise and Activity in Chronic Fatigue Syndrome: A Pilot Study. Journal of Chronic Fatigue Syndrome, Vol. 12, Iss. 2, pp. 51-66. http://dx.doi.org/10.1300/J092v12n02_06
  7. Reeves, W. C.; Lloyd, A.; Vernon, S. D.; Klimas, N.; Jason, L. A.; Bleijenberg, G.; Evengard, B.; White, P. D.; Nisenbaum, R.; Unger, E. (2003), "Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution", BMC Health Services Research, 3 (25), doi:10.1186/1472-6963-3-25